Oramed Pharmaceuticals Inc. (ORMP) – Buy Price: $3.60 or better

Buy Price: $3.60 or better
Sell Price: TradersPro Sell Signal

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Its product portfolio includes ORMD-0801, which completed phase II clinical trials is an orally ingestible insulin capsule for the treatment of diabetes; and ORMD-0901 that completed phase I clinical trials is an oral glucagon-like peptide-1 analog capsule for the treatment of type 2 diabetes.


© Copyright 2020 Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.